London · Delayed Price · Currency is GBP · Price in GBX CAP-XX Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 9% year-over-year with bookings up 31% and backlog up 132%, while net loss and EBITDA loss both improved. Cash on hand reached AUD 2.9 million, with no debt and all legal cases closed. Expansion into new markets and product lines supports a positive outlook.
Fiscal Year 2025
-
The AGM covered board elections, adoption of a new constitution, auditor appointment, and authorization for future securities issuance. All five resolutions passed with 89–91% support from shareholders, representing 28.58% of issued share capital.
-
Revenue grew 8% in FY2025 with strong margins and reduced losses, driven by operational improvements and expanded distribution. Bookings and billings are up in early FY2026, and management expects continued growth and progress toward profitability.
-
Revenue grew 6.8% year-on-year, with strong APAC performance and reduced losses from cost-cutting. New partnerships and product launches are driving growth, and cash reserves are expected to last up to 24 months as the company targets break-even without further capital raises.
-
The meeting covered board changes, strong director re-elections, and approval of a share capital policy. Shareholders' questions addressed strategic growth, product development, and market expansion, with objectives set for market share growth and positive cash flow in 2025/26.